Alzheimer's drug developer Probiodrug, the backers of which include Biogen Idec, has set the range for a proposed initial public offering in the Netherlands.

Intrexon plans to invest $15m in the tissue implant developer as part of its initial public offering, which will support its product candidate through Phase 3 trials.

Legend-backed fashioner designer and retailer Chapelle Fashion has raised $219m in an IPO that featured $50m in corporate investment.

Life sciences company Great Basin, which closed a $7.6m series D round featuring Hitachi Chemical in April, has raised more than $8m from its initial public offering.

The Google and Salesforce-backed sales and marketing software company floated at $25.00, substantially higher than its $19 to $21 range.

Auto rental company eHi has filed for an initial public offering in the US, less than a year after raising $100m in a round led by online travel service Ctrip.

ACI and Bank of America are both shareholders in the account aggregation company.

Pharmaceutical firm UCB invested $7.5m as the dermatology company floated at the top of its range.

FibroGen, a Astellas-backed biotech firm, is lining up a $125m initial public offering to raise money for further drug development.

The Israel-based company, backed by investors including Yaskawa Electric, intends to spend the proceeds on sales, marketing and product development.